Antibiotics resistance mechanism
- Bacteria develop ability to hydrolyze these drugs using β lactamase
- confers resistance to penicillin
- e.g. E. coli, Staph epidermidis, Pseudomonas aeruginosa, Klebsiella pneumoniae
- add β lactamase inhibitor e.g. clavulanic acid in amoxicillin-clavulanate (Augmentin)
- Genetic mutation of mecA
- carried by Staphylococcal cassette chromosome (SCCmec) mobile genetic unit
- a bacterial gene encoding a penicillin-binding protein (PBP2a).
- PBP2a has reduced affinity for antibiotics
- confers resistance to methicillin, oxacillin, nafcillin
- e.g. MRSA
- SCCmec type IV has less genetic elements and is specific to CA-MRSA, making CA-MRSA less multi-drug resistant
- Altered cell wall permeability
- confers resistance to tetracyclines, quinolones, trimethoprim and β lactam antibiotics
- Creation of biofilm barrier
- provides an environment where offending bacteria can multiply safe from the hoste immune system
- Salmonella
- Staph epidermidis
- provides an environment where offending bacteria can multiply safe from the hoste immune system
- Active efflux pumps
- confers resistance to erythromycin and tetracycline
- e.g. msrA gene in Staph
- Altered peptidoglycan subunit (altered D-alanyl-D-alanine of NAM/NAG-peptide)
- confers resistance to vancomycin
- e.g. vancomycin resistant enterococcus (VRE)
- Ribosome alteration
- erm gene confer inducible resistance to MLS (macrolide lincosamide streptogranin) agents via methylation of 23s rRNA
- demonstrate using D zone test
- for inducible clindamycin resistance in Staph and beta hemolytic Strep
Comments
Post a Comment